Company intelligence / Profile preview

Panacea Biotec

New Delhi, Delhi, Indiapanaceabiotec.com ↗
Ownership
Private
Employees
~1146
Development stage
Commercial
01

Overview

Panacea Biotec has commercialized over 120 drugs including globally significant pediatric combination vaccines like EasyFive and EasySix. The company’s hexavalent vaccine EasySix was the world’s first fully liquid wP-based hexavalent vaccine protecting against six childhood diseases. It regained WHO prequalification after earlier quality issues were resolved. The company also has COVID-related candidates in its pipeline and recently expanded manufacturing capacity with international financing support for global supply through UN agencies.

Therapeutic areas
NephrologyEndocrinologyOtherOncologyInfectious Diseases
Modalities
Vaccinessmall moleculesmonoclonal antibodiesbiosimilarsnutraceuticals
Industry
Biotech
02

Drug pipeline

15 assets

Td Vaccine

Approved

14 more assets in the full pipeline.

Request access →
03

Partnerships

Russian Direct Investment Fund for Sputnik V productionUNICEF/Gavi/PAHO supply partnerships for global immunizationUS International Development Finance Corporation loan partnership for manufacturing expansion

Beyond the preview

Go deeper on Panacea Biotec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panacea Biotec.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call